Medaka twist, a basic helix-loop-helix (bHLH) transcription factor, is expressed in the sclerotome during embryogenesis. We previously established a line of twist -EGFP transgenic medaka, whose EGFP expression is regulated by the twist promoter; therefore, we could observe the behavior of sclerotomal cells in vivo. In the transgenic medaka embryos, EGFP-positive sclerotomal cells migrated dorsally around the notochord and the neural tube, where at a later stage the vertebral column would be formed. This finding strongly suggests that twistexpressing sclerotomal cells participate in vertebral column formation in medaka. To clarify the function of twist gene in the sclerotome, we performed knockdown analysis of twist by using two kinds of morpholino antisense oligonucleotides targeted against twist (MO1 and MO2). Both the MO1 and MO2 morphants exhibited absence of neural arches, which are bilaterally paired, dorsomedially oriented bones on the dorsal aspect of the centrum. In addition, MO2, which blocks translation of only endogenous twist mRNA in the twist -EGFP transgenic medaka, did not affect the migration pattern of EGFP-positive cells, revealing that the migration of sclerotome-derived cells were normal in the absence of twist gene function. These results demonstrate that medaka twist functions in vertebral column formation by regulating the sclerotomal cell differentiation. q
Introduction
The vertebral column is an anterior -posterior series of bones surrounding the notochord and the neural tube of vertebrates. The vertebral column in mammals includes the vertebral body, the neural arch, and the intervertebral disks between adjacent vertebral bodies. Vertebral column development requires the participation of both the sclerotome and the notochord. The sclerotome, which is a population of undifferentiated mesenchymal cells, is derived from the somitic mesoderm by the action of diffusible signaling molecules Sonic hedgehog (Shh) and Noggin that are secreted from the notochord and floorplate; and it occupies the ventromedial region in each somite (Dockter, 2000) . These progenitor cells of sclerotome differentiate into chondrocytes to give rise to the cartilaginous precursor of the axial skeleton that is later replaced by bone in mammals and avians (Christ and Wilting, 1992) . In fact, the Shh mutant mice lack most of the sclerotomal derivatives including the entire vertebral column (Chiang et al., 1996) .
Several sclerotome-specific genes such as Pax1, Pax9, and Bapx1 are known, and mice with their mutant genes have already been analyzed. Pax1 and Pax9 are similarly expressed in the pharyngeal pouches and the developing limbs, and these are the only genes expressed in the sclerotome among the Pax gene family during mouse embryogenesis (Neubuser et al., 1995) . The Pax1-deficient mice exhibit morphological abnormalities of the vertebral column and intervertebral disks, whereas the Pax9-deficient mice have no defect in its axial skeleton Wilm et al., 1998) . However, the vertebral column of the Pax1/Pax9 double homozygous mutant mice is severely affected; ossified vertebral bodies are completely absent, although neural arches are normally formed (Peters et al., 1999) . Moreover, in the absence of Bapx1, a direct target molecule of Pax1 and Pax9, the same phenotype as seen in the Pax1/Pax9 double mutant mice is observed in the axial skeleton (Akazawa et al., 2000; Herbrand et al., 2002; Lettice et al., 1999; Tribioli and Lufkin, 1999) . In either the bapx1 mutant or the pax1/pax9 double mutant mice, no prototypes of vertebral body derived from cartilaginous tissues are detected. Taken together, these reports indicate that Shh-induced Pax1/Pax9 signaling is indispensable for sclerotomal cells to obtain the potential to differentiate into chondrocytes in the presence of BMP signaling from the lateral plate mesoderm (Murtaugh et al., 1999; Rodrigo et al., 2003) Twist gene, which encodes a transcription factor harboring bHLH domain, was first identified as a zygotic gene responsible for the Drosophila spontaneous mutant that dies at the end of its embryogenesis without forming mesodermal germ layer (Nusslein-Volhard et al., 1984; Simpson, 1983; Thisse et al., 1987 Thisse et al., , 1988 ; therefore, twist has been considered as a mesoderm-determining factor (Castanon and Baylies, 2002) . In vertebrates, twist is mainly expressed in mesoderm-derived tissues including the head mesenchyme, branchial arches, limb buds and sclerotome (Fuchtbauer, 1995; Gitelman, 1997; Morin-Kensicki and Eisen, 1997; Soo et al., 2002; Stoetzel et al., 1995; Tavares et al., 2001; Wolf et al., 1991) . In the Twist heterozygous mutant mice, the vertebral column is normally developed, but abnormalities are observed in the craniofacial structures and the phalanges (Bourgeois et al., 1998; el Ghouzzi et al., 1997) . Patients affected Saethre -Chotzen syndrome, an autosomal dominant hereditary disease caused by a TWIST mutation, exhibit some malformations similar to that of the Twist heterozygous mutant mice; thus no defect is observed in their axial skeleton (Bourgeois et al., 1998; el Ghouzzi et al., 1997; Howard et al., 1997) . On the other hand, the development of the vertebral column in the Twist homozygous mutant mice is not observed because those Twistnull mutant embryos fail to undergo closure of the cephalic neural tube and die at E11.5 (Chen and Behringer, 1995) . Therefore, the relationship between Twist and the vertebral column remains unclear in the mouse, although Twist is definitely expressed in the sclerotome and would be expected to play an important role in axial skeletal development.
Medaka and zebrafish have been demonstrated to be useful model organisms for the study of vertebrate osteogenesis (Du et al., 2001; Fisher and Halpern, 1999; Fisher et al., 2003; Fleming et al., 2004; Inohaya and Kudo, 2000; Morin-Kensicki et al., 2002; van Eeden et al., 1996) . It is also suggested that the molecular mechanism of osteoblast and chondrocyte differentiation is well conserved between teleosts and mammals (Fisher et al., 2003; Inohaya and Kudo, 2000) . The vertebral column of medaka is composed of the centrum (vertebral body), the neural arch and the hemal arch, and its fundamental structure resembles that of mammals. Furthermore, the medaka vertebral column is easily observed under the microscope on account of the transparency of the body throughout ontogenesis, and gene manipulation can also be carried out by injection into the fertilized eggs. By making the most of these advantages, we analyzed the function of twist during medaka embryogenesis in a reverse genetics method. As a result, we demonstrate here that twist might regulate the differentiation of sclerotome-derived cells into osteoblasts to give rise to the neural arches. This report is significant in the aspect of examining the twist gene function in the axial skeletal development of vertebrates for the first time.
Results

Expression patterns of medaka twist and other sclerotome markers
We cloned the full-length medaka twist gene from the cDNA library of day 3 -4 embryos (stage 28-30). Fig. 1A shows the nucleotide sequence and the predicted amino acid sequence of medaka twist gene. We found that medaka twist contained 57 amino acids of a bHLH region as defined by Murre et al. (1989) , which was highly conserved among vertebrates (Fig. 1B) . We then examined the expression pattern of medaka twist by in situ hybridization. The expression of twist was first detected in the sclerotome located at the ventromedial part of each somite at early day 2 (stage 22), and at this time, twist was also expressed in mesenchymal cells of the embryonic head and in the putative trunk neural crest cells (Vaglia and Hall, 2000) ( Fig. 2A -C) . The twist expression was specifically maintained in the embryonic head and in the sclerotome at late day 2 (stage 25) (Fig. 2D -F) . Next, we performed a comparative analysis of the expression patterns between the sclerotome markers by in situ hybridization. The expression of sclerotome markers such as pax9 (Fig. 2H ) and bapx1 ( Fig. 2I) were observed at the ventromedial part of each somite, which was similar to that of twist (Fig. 2G) ; whereas myoD, a differentiation marker of myotome, was expressed broadly in each somite (Fig. 2J ). In addition, myoD was expressed immediately in the myotome after the somites had formed from the paraxial mesoderm, whereas the twist expression in the sclerotome lagged behind the myoD expression in the myotome (data not shown). From these results, we considered medaka twist to be one of the genes defining the sclerotome in medaka.
Migration of sclerotomal cells in twist-EGFP transgenic medaka
To investigate the function of twist gene in the sclerotome, we first characterized the sclerotomal development during medaka embryogenesis. Recently, we have succeeded in establishing a twist -EGFP transgenic line that stably expressed EGFP under the control of the medaka twist promoter (Inohaya et al., in preparation).
The expression pattern of EGFP in this transgenic medaka was similar to those of endogenous medaka twist as described in Fig. 2A -F . Thus, a series of observations of the EGFP distribution in a whole embryo of an identical transgenic medaka enabled us to easily trace the sclerotomederived cells throughout ontogenesis by using fluorescence microscopy (data not shown).
We performed a histological analysis of this transgenic medaka at the various developmental stages to clarify the distribution of EGFP-positive sclerotomal cells in detail. In a transverse section of the day-2 embryos, sclerotomal cells expressing EGFP were observed in the most ventral portion of the somite (Fig. 3A) . These EGFP-positive cells migrated dorsally (Fig. 3B) , and became distributed around the notochord, neural tube and dorsal aorta (Fig. 3C) , where the vertebral column would be formed later. In medaka, the ossification of a vertebral column starts from the anterior part of the body in the day-5 embryos (Ogawa, 1965; Inohaya et al., in preparation) ; therefore, it is necessary for sclerotome-derived cells to be distributed in the putative vertebral column-forming area before calcified bony tissues appear there. We suggest that these sclerotome-derived cells differentiate into osteoblasts at a later embryonic stage to give rise to the vertebral column. Thereafter, EGFP-positive cells were observed mainly around the notochord in the day-6 embryos ( Fig. 3D) . This distribution pattern of twist-positive sclerotomal cells strongly suggests that medaka twist functions in vertebral column formation.
Absence of neural arches in MO1-injected larvae
In order to analyze the function of medaka twist gene during sclerotomal development, we interfered with twist function by injecting morpholino antisense oligonucleotides. Two kinds of morpholinos targeted against medaka twist, MO1 and MO2, were used in the present study (Fig. 1A) . MO1 was designed according to a part of the 5 0 -untranslated region sequence of medaka twist that is shared by endogenous twist mRNA and the introduced EGFP mRNA in the twist -EGFP transgenic line (Fig. 4A ). Therefore MO1 was expected to simultaneously inhibit the expression of both endogenous twist and exogenous EGFP in the transgenic embryos. Consequently, we were able to monitor the inhibitory effect of the morpholino antisense oligonucleotides on living specimens by observing the EGFP expression. As a result of MO1 injection into the transgenic embryos, EGFP expression was completely suppressed in the whole embryonic body until day 2 ( Fig. 4F -G) . However, weak expression became detectable in the embryonic head from day 3 (Fig. 4H ) and also in sclerotomes from day 4 (Fig. 4I ) in the MO1-injected transgenic embryos. These results indicate that the morpholino antisense method was effective at least until day 3 in the sclerotome of medaka embryos.
The abnormalities of the MO1-injected embryos were induced in a concentration-dependent manner in the present study. A high concentration of MO1 (0.5 mM) led to cranial malformations such as a defective head skeleton and asymmetrical eye formation at the early developmental stage (Fig. 4O ). In these cases, the morphants died without having formed a vertebral column. In contrast, when MO1 was injected at a low concentration (0.06 -0.09 mM), some of the neural arches were lost in the larvae whose vertebral column had been visualized by alizarin red staining at 4 -5 days after hatching ( Fig. 4J -M, and Table 1 ). MO1 at this concentration was not effective in disrupting the cranial skeleton at the early embryonic stage (data not shown). The absence of neural arches tended to occur at the anterior part of the body, from which the ossification of axial skeleton begins during medaka embryogenesis (data not shown). Moreover, in the MO1 morphants, some vertebrae lacked both of the neural arches that were located bilaterally at the anterior end of centra, whereas other vertebrae lacked either of them (Fig. 4M) . In some MO1-injected larvae, partially formed neural arches were observed within the precise sites where normal neural arches should arise (Fig. 4N) . It must be noted that both the hemal arches and the centra were normally formed and patterned in these morphants (Fig. 4L, N) . Other tissues along the axial skeleton such as skeletal muscles and intersegmental vessels also seemed to have normally been developed. Additionally, the embryos injected with control morpholino (Control MO) either at a high or at a low concentration normally developed without any abnormalities in their cranial skeleton or vertebral column (Fig. 4J,K) .
To examine the sclerotomal development in the twist morphants, we performed in situ hybridization analysis using sclerotome markers as probes. As a result, there were no differences in the expression patterns of twist (Fig. 5A,E) , pax9 (Fig. 5B,F) , and bapx1 (Fig. 5C,G) between the uninjected embryos and the embryos injected with MO1 at a low concentration. These results indicate that the sclerotome was normally developed in the twist morphants. The myotome development was also normal in these morphants (Fig. 5D,H) . In addition, we examined the cranial cartilage structure of the MO1-injected larvae at 2 days after hatching, and the alcian blue staining showed that the cranial cartilage formation was not affected in the larvae injected with MO1 at a low concentration (Fig. 5I,J) .
2.4. Normal migration of sclerotomal cells in twist-EGFP transgenic medaka embryos in the absence of twist function caused by MO2
Another morpholino, MO2, was designed according to the nucleotide sequence at the translation start site of medaka twist (Figs. 1A,6A ). Since MO2 was expected to disrupt translation of only endogenous twist transcripts even if injected into twist -EGFP transgenic medaka embryos, we were able to trace the sclerotome-derived cells that were expressing exogenous EGFP but not endogenous twist. The MO2 morphants (low concentration: 0.03 -0.06 mM) exhibited the same phenotype as the MO1 morphants (Fig. 6B,C and Table 1 ), confirming that the absence of neural arches was caused by twist knockdown. Next, we examined the EGFP expression in the MO2 morphants to investigate the migration pattern of the sclerotomal cells under this twist knockdown condition. Our observations made with the fluorescence binocular microscope showed that the EGFP expression patterns seemed to be normal in the MO2-injected transgenic embryos at day 3 (Fig. 6D -G ) or day 6 (Fig. 6H,I ). Moreover, we performed in situ hybridization for EGFP mRNA in the uninjected and the MO2-injected embryos to confirm the distribution of the EGFP-positive sclerotomal cells in detail. As a result, there were no differences in the distribution of the sclerotomal cells between the uninjected embryos ( Fig. 6J ) and the MO2 morphants (n ¼ 20; Fig. 6K ) at day 3. These results strongly suggest that the migration of sclerotome-derived cells was not affected by twist knockdown. Therefore, we conclude that medaka twist functions in the differentiation process of the sclerotomal cells into the neural arch-forming osteoblasts but not in the migration.
Discussion
Twist is a bHLH transcription factor whose sequence is widely conserved among various species. Twist cDNA, which we isolated from medaka in the present study, was cleared to be homologous to those of other vertebrates. This gene was strongly expressed in the sclerotome during medaka embryogenesis, as other vertebrates' twist genes are (Fuchtbauer, 1995; Gitelman, 1997; Soo et al., 2002; Stoetzel et al., 1995; Tavares et al., 2001; Wolf et al., 1991) . We fully expected that twist might be involved in sclerotomal development of vertebrates including medaka; thus, we sought to clarify the function of twist in the sclerotome by focusing on the relationship between twist gene function and the axial skeletal formation in medaka. This is the first report that highlights the necessity of twist gene for neural arch formation in teleosts, raising the possibility that the twist gene plays a similar and significant role in mammals as well. Injection of MO1 and MO2 resulted in absence of neural arches. a We counted when one or more neural arches were absent. b Malformation in head morphogenesis was included.
Efficiency of morpholino knockdown in medaka
We performed the morpholino oligonucleotide injection as a method for knockdown to examine the twist function during medaka development. Many researchers have used morpholino oligonucleotides to block translation of targeted genes, and have accumulated data showing the effect of morpholino. In their reports, it was demonstrated that morpholinos were useful in various species (Heasman, 2002) . Especially in zebrafish, Nasevicius and Ekker (2000) revealed that morpholino could remove gene function from maternal through post-segmentation and organogenesis developmental stages by being injected into the yolk of fertilized eggs. In contrast, only a few studies involving morpholino knockdown experiments on medaka have been reported (Carl et al., 2002; Yamamoto et al., 2003) .
We considered that the twist -EGFP transgenic medaka line is a suitable model to clarify the efficiency of the morpholino antisense method during medaka embryogenesis. MO1 has the sequence complementary to the common nucleotide sequences among the endogenous twist gene and the exogenous EGFP gene encompassing the twist promoter region. The effectiveness of MO1 was determined by examining EGFP expression in the twist -EGFP transgenic embryos. As a result of the injection of MO1 into the blastomere at the one-cell stage, EGFP expression in the sclerotome was strongly inhibited until day 3 after fertilization in the MO1-injected transgenic embryos. This finding indicates that MO1 had definitely been inhibiting translation of endogenous twist mRNA as well as that of EGFP mRNA in the sclerotome at least until day 3. According to our histological analysis, the sclerotomal cells begin to migrate dorsally to the surface of the notochord and neural tube starting from day 2, and the differentiation is indicated to take place after the migration. Taken together, the absence of neural arches in the twist morphants suggests that the function of twist gene was important until day 3 for the formation of the neural arches.
Twist is required for neural arch formation in medaka
Our study demonstrates by morpholino knockdown that medaka twist is involved in neural arch formation. The absence of neural arches was the consequence of the injections of two different types of morpholinos targeted against twist, MO1 and MO2, revealing that the loss of twist function caused this phenotype. However, the morphants never showed a phenotype in which all neural arches along the anterior -posterior axis were completely extinguished, although some neural arches were definitely lost. This might have arisen from the limit of morpholino function at the later stage, as described above.
Severe phenotypes were observed in the head morphogenesis when the morpholino was injected at a high concentration. These phenotypes contained, for example, asymmetrical eye formation, delayed head development and a small head skeleton. Embryos with these severe phenotypes died before starting the formation of the axial skeleton. This finding strongly indicates that the absence of neural arches was induced by the loss of twist function especially when MO1 was injected at the appropriate concentration. In situ hybridization of sclerotomal marker genes such as pax9 and bapx1 revealed that their expression patterns were normal in the twist morphants, suggesting that the sclerotome was certainly generated in the absence of twist function, and moreover, that the character of sclerotomal cells was not altered under the twist knockdown condition. So we speculate on the possibility that twist participates in neural arch formation by regulating either the migration to the notochord and neural tube or the differentiation of the sclerotomal cells.
Twist does not function in the migration but in the differentiation of sclerotomal cells into osteoblasts that give rise to neural arches
We investigated whether sclerotomal cells migrate normally in the absence of twist function by using the twist -EGFP transgenic line. The migration of sclerotomal cells was easily observed in day-3 embryos of the twist -EGFP transgenic line. To utilize this advantage, we designed another morpholino, MO2 in the present study, for twist knockdown. We first checked that MO2 was definitely working by obtaining the MO2 morphants with the same phenotype as shown by the MO1 morphants. If the loss of twist function causes unusual migration of sclerotomal cells, then changes in the behavior of EGFP-positive cells should be detected. This is because EGFP expression was expected to be maintained in sclerotome-derived cells in the MO2-injected transgenic embryos, whereas endogenous twist expression itself was inhibited. MO2 injection into the twist -EGFP transgenic medaka resulted in no difference in the EGFP expression patterns, suggesting that the loss of twist function did not affect the migration of sclerotomal cells that finally give rise to the neural arches. We add here that the normal migration was also confirmed by in situ hybridization of EGFP mRNA at day 3.
The remaining possibility to explain the absence of neural arches was the abnormal differentiation of the sclerotomal cells. In medaka, cartilages are not observed throughout its vertebral column formation (Ekanayake and Hall, 1987 , 1990 . Therefore, it seems that sclerotomal cells, which are kept in the undifferentiated condition, differentiate directly into osteoblasts but not into chondrocytes, suggesting that the medaka vertebral column is developed through intramembranous ossification and not endochondral ossification. We considered the possibility that the differentiation of sclerotomal cells into neural archforming osteoblasts might be inhibited in the twist morphants and consequently the neural arches were absent, although their migration had been completed. This possibility was verified by the following results: some larvae injected with MO1 exhibited incomplete formation of their neural arches. In these larvae, such neural arches were not fully ossified, and thus partial bony tissues were only observed. Some looked like the short protuberance attached to the adjacent centrum, and some looked like the independent island-like ossification distal to the centra. In particular, these island-like partial ossifications were located in the precise sites where normal neural arches should be formed. This phenomenon could not have occurred if the sclerotome-derived cells had not completed their dorsal migration in the right way and become normally distributed. In other words, if the migration and distribution had been affected by twist knockdown, the partial neural arches could have been placed ectopically. Therefore, these data strongly suggest that the sclerotomal cells normally migrated but that their differentiation into osteoblasts, which give rise to the neural arches, was inhibited by the loss of twist function. We conclude that twist is one of the regulatory molecules of the sclerotomal differentiation in medaka.
Molecular mechanism of vertebral column development
In mouse, numerous previous studies have suggested that several genes expressed in the sclerotome control the axial skeletal development. Each vertebra is assembled from multiple elements; these elements including the vertebral body and the neural arch are suggested to be regulated by independent developmental pathways (Peters et al., 1999) . In fact, analyses on mutant mice which lack the vertebral bodies especially have revealed the requirement of the Pax1/Pax9-dependent pathway involving Bapx1 for the vertebral body development (Akazawa et al., 2000; Herbrand et al., 2002; Lettice et al., 1999; Peters et al., 1998 Peters et al., , 1999 Tribioli and Lufkin, 1999; Wilm et al., 1998) . However, the mutant mice lacking the other elements of the vertebral column have not been generated so far, and thus no genes or pathways that specifically participate in the neural arch development have been found.
On the other hand, in the teleost, the analysis of zebrafish fused somites ( fss) mutant has revealed that the centra of this mutant are normal in number and shape whereas the neural arches grow in an irregular fashion at the ectopic position, suggesting the potential distinctions between the neural arch and the centrum development (van Eeden et al., 1996) . In the present report, medaka twist, which is expressed in the sclerotome, was demonstrated by morpholino knockdown to be involved specifically in the development of the neural arch. This finding implies that twist independently functions in sclerotomal cells as a key molecule for the neural arch formation. Based on our present study, we hypothesize that neural arches and vertebral bodies originate individually from different types of sclerotomal cells, and that these two kinds of cells are individually regulated by different molecular mechanisms; twist may prescribe the cells involved in the neural arch formation, and pax1/pax9/bapx1, those in the centrum formation.
Materials and methods
Fish strains and embryos
Analyses in the present study were performed using himedaka, a conventional wild-type medaka, and two different inbred lines: qurt and d-rR. Embryos were incubated at 30 8C after collection, and staged according to Iwamatsu (1994) .
Cloning of full-length medaka twist cDNA
We previously amplified a medaka twist cDNA fragment (Inohaya et al., in preparation) . This twist cDNA fragment was used to probe a medaka cDNA library constructed from day 3 -4 embryos (stage 28 -30). Digoxigenin (DIG)-labeled probes were amplified with PCR DIG Probe Synthesis Kit (Roche) according to the manufacturer's instructions. Nylon filters, to which lZAPII clones had been transferred, were hybridized overnight at 42 8C in DIG Easy Hyb (Roche). After hybridization, the filters were washed twice in 2 £ SSC/0.1% SDS at room temperature, for 15 min each time and then twice in 0.1 £ SSC/0.1% SDS at 68 8C, for 30 min each time. The hybridized filters were washed twice with buffer 1 (0.1 M maleic acid, 0.15 M NaCl, 0.3% Tween-20; pH7.5) for 5 min at room temperature, and washed with buffer 2 (10% blocking reagent in buffer 1) for 30 min at room temperature. Then, the filters were incubated with 1/10000-diluted anti-DIG-AP antibody (Roche) in buffer 2 for 20 min at room temperature. Following two washes with buffer 1, the filters were incubated with 1/200-diluted CSPD (Roche) for 4 min at room temperature and exposed for an appropriate period of time to X-ray film. The nucleic acid sequence of medaka twist was deposited in the DDBJ/EMBL/GenBank, whose accession number is AB158192.
Morpholino knockdown
For the loss of twist gene function analysis, two kinds of morpholino-modified antisense oligonucleotides, MO1 and MO2 (see Fig. 1A ), were purchased from Gene Tools, LLC (Corvalis, OR). MO1 (5 0 -GGCGTCCACCAGACAGAGT-CACAGC-3 0 ) targets the sequence in the 5 0 -untranslated region of twist mRNA (between 39 and 14 bp upstream of the ATG start codon), while MO2 (5 0 -CTCCCAA-ATTTTCCTCAGACATCCC-3 0 ) targets the sequence at the translation start site of twist mRNA. As a control experiment, Standard Control Morpholino Oligo (Control MO, 5 0 -CCTCTTACCTCAGTTACAATTTATA-3 0 ) recommended by Gene Tools was used. Morpholino oligonucleotides were dissolved in RNase-free water to make a final concentration of 0.03-0.5 mM. (0.5 mM for injections at a high concentration, 0.03 -0.09 mM for injections at a low concentration), and the solutions were marked by phenol red. These morpholino dilutions were injected into the blastomere of wild-type or twist -EGFP transgenic embryos at the one-cell stage. The injected volume was about 4 nl.
Whole-mount RNA in situ hybridization
Whole-mount in situ hybridization was performed, using a modified protocol of Inohaya et al. (1995 Inohaya et al. ( , 1999 . Embryos were fixed overnight in 4% paraformaldehyde at 4 8C. The fixed embryos were dechorionated, washed twice in PBST (0.1% Tween-20 in phosphate-buffered saline), and gradually transferred to 100% methanol through a methanol series (25, 50, 75% methanol in PBST) for dehydration. The dehydrated embryos were then rehydrated by transferring to PBST through a reversed methanol series (75, 50, 25% methanol in PBST). After washing twice in PBST, the embryos were treated with Proteinase K (Roche, 10 mg/ml in PBST) for 5-10 min at 37 8C and refixed for 20 min in 4% paraformaldehyde at room temperature. Following several washes with PBST, the embryos were prehybridized for 2-3 h in the hybridization buffer (50% formamide, 0.1% Tween-20, 50 mg/ml tRNA, 50 mg/ml heparin, 2 £ SSC) at 70 8C, and then hybridized overnight with DIG-labeled antisense RNA probe (100 -200 ng) in the hybridization buffer at 70 8C. The hybridized embryos were washed four times in 50% formamide/2 £ SSC for 30 min each time at 70 8C, twice in 2 £ SSC for 15 min each time at 70 8C, twice in 0.2 £ SSC for 20 min each time at 70 8C, and three times in PBST for 10 min each time at room temperature. The embryos were then blocked for 2 -3 h by incubating with 5% lamb serum in PBST at room temperature. After the blocking, the embryos were incubated overnight at 4 8C with 1/8000-diluted anti-DIG-AP antibody (Roche) in PBST. The antibody had been preabsorbed in advance by incubating with homogenized medaka embryos at various stages for 3-5 h at room temperature. Following six washes in PBST for 30 min each time at room temperature, the embryos were further washed three times in NTMT (100 mM NaCl, 100 mM Tris-HCl, pH 9.5, 50 mM MgCl 2 , 0.1% Tween-20) for 10 min each time at room temperature. Finally, the embryos were incubated in NTMT containing 3.5 ml NBT (4-nitro blue terazolium chloride, Roche, 100 mg/ml) and 3.5 ml BCIP (5-bromo-4-chloro-3-indolyl-phosphate, Roche, 50 mg/ml) per 1 ml in the dark. The colored embryos were washed several times in PBST and photographed in 2% methylcellulose.
Whole-mount skeletal staining
Alizarin red staining was carried out for the visualization of calcified bones. Larvae at 4 -5 days after hatching, which were incubated at 30 8C, were fixed overnight in 4% paraformaldehyde with 0.05N sodium hydroxide at room temperature. After briefly washing in PBST, the fixed larvae were stained in alizarin red solution (4% alizarin red, 0.5% potassium hydroxide) at room temperature for several hours or overnight. Stained preparations were stored in 0.5% potassium hydroxide and photographed in 2% methylcellulose. For the visualization of cartilage structures, larvae at 2 days after hatching were fixed overnight in 4% paraformaldehyde at room temperature and then washed several times in PBST. The larvae were stained overnight in alcian blue solution (0.1% alcian blue, 70% ethanol, 30% glacial acetic acid). After gradual transference to PBST through an ethanol series, the specimens were bleached with hydrogen peroxide (3% hydrogen peroxide, 1% potassium hydroxide) for 1 h or until their eyes had become transparent, and washed several times in PBST. Then the larvae were treated with 0.1 -1% trypsin in a 30% sodium borate saturated solution at room temperature for less than 1 h. Stained preparations were mounted in 2% methylcellulose and photographed.
Histology
For the sectioning of the twist -EGFP transgenic line, EGFP homozygous transgenic embryos at days 2 -6 were collected and sectioned according to a modification of the original protocol (Inohaya et al., 1995) . Embryos were fixed overnight in 4% paraformaldehyde at room temperature, dechorionated, and washed several times in PBST. The fixed embryos were then transferred to 15% sucrose in 0.1 M phosphate buffer (PB) and kept overnight, and subsequently embedded overnight in 10% gelatin and 15% sucrose in 0.1 M PB at 4 8C. Embryos embedded in gelatin blocks were then frozen and sectioned at 20 mm with a microtome. EGFP distribution in each section was observed and photographed.
